Company Search:
Advanced Search
Sponsored Links
Weifa ASA Company Snapshot
Weifa ASA operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Weifa ASA with three other miscellaneous service companies in Europe: MorphoSys AG of Germany (2016 sales of 49.74 million Euro [US$59.01 million] of which 99% was Partnered Discovery), Karo Pharma AB of Sweden (347.26 million Swedish Kronor [US$42.88 million] of which 100% was Drugs Discovery & Dev), and Ergomed PLC which is based in the United Kingdom (£39.23 million [US$52.24 million] of which 67% was Clinical Research Service).

Sales Analysis. Weifa ASA reported sales of NOK 399.11 million (US$50.73 million) for the year ending December of 2016. This represents an increase of 20.2% versus 2015, when the company's sales were NOK 332.04 million. This was the third consecutive year of growth at Weifa ASA.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Weifa ASA
  Stock Performance Chart for Weifa ASA
  Stock Data: Recent Stock Performance:
  Current Price (10/12/2017): 34.90
(Figures in Norwegian Kroner)
1 Week 0.3%   13 Weeks 0.0%  
4 Weeks 17.9%   52 Weeks 50.4%  
Weifa ASA Key Data:
  Ticker: WEIFA Country: Norway
  Exchanges: OSL Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 399,113,000
(Year Ending Jan 2017).
Employees: 30
  Currency: Norwegian Kroner Market Cap: 1,272,875,208
  Fiscal Yr Ends: December Shares Outstanding: 36,472,069
  Share Type: Ordinaere Aksje Closely Held Shares: 8,654,627
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.